Osimertinib is prescribed to prevent the recurrence of non-small-cell lung cancer after it is removed surgically. This drug can also be used as the first treatment for certain types of non-small-cell lung cancer that have spread to other parts of the body. It belongs to the drug group called kinase inhibitors.
Hello, Welcome to icliniq.com. I have read your query. I understand why this feels confusing.
Hello, Welcome to icliniq.com. I understand your concern. First of all, I am very sorry that you and your husband are facing such a difficult and unexpected diagnosis.
Hello, Welcome to icliniq.com. I have read your query. I can understand how overwhelming this must feel.
Hi, Welcome to icliniq.
Hi, Welcome to icliniq.com. In reply to your question for Osimertinib (Tagrisso), Osimertinib demonstrated improvement in PFS (18.9 versus 10.2 months, HR 0.46, 95% CI 0.37-0.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.
